Novel Imaging for Genitourinary Cancers

Novel Imaging for Genitourinary Cancers Host: Jay D. Raman, MD, FACS Co-Host: Marc Bjurlin, DO CME Available: https://auau.auanet.org/node/37333 At the conclusion of this activity, participants will be able to 1. Review clinical trials and available PET imaging agents for the detection of prostate, kidney and urothelial cancer. 2. Assess the indications, risks, and benefits of incorporating PET imaging to guide treatment of urologic cancer. ACKNOWLEDGEMENTS: This series is supported by independent educational grants from: Astellas AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Lantheus Medical Imaging Merck & Co., Inc. Pfizer, Inc. Sanofi Genzyme